Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From 4basebio AG
Asia Deal Watch: China Grand, ETheRNA Create mRNA Vaccine JV
Plus deals involving LegoChem/Pyxix, Biohaven/Sosei Heptares, Kyowa Kirin/Helsinn, Dr. Reddy’s/Glenmark, Eisai/Wren, KoBioLabs/Kolmar Korea, Y-Biologics/Pierre Fabre, Generex/Chinese consortium.
Finance Watch: Gossamer Works Around The Shutdown To Price Its $230m IPO
Gossamer took an infrequently used path to go public during a US government shutdown that's kept the SEC from processing new offerings. Also, IPO filings (and withdrawals) and follow-on offerings continued during the shutdown, while VC deals keep up a brisk pace.
Deal Watch: Novo’s Increased Cell Therapy Commitment Includes Stem Cell Pact With BioLamina
Also, TapImmune merger with Marker could yield T-cell therapies that address multiple tumor-associated antigens with a better safety profile than CAR-T therapy. Bluebird and Medigene expand their TCR therapy collaboration.
Workforce Roundtable Part 3: Diversity And Progress – And Advice For Biopharma's Next Generation
Women in leadership roles has become a much discussed issue for the biopharma industry, but less attention seems to be focused on racial diversity. Scrip's panel talks about challenges and opportunities, and offers advice for next generation employees.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Contract Manufacturing Organization
- Antisense, Oligonucleotides
- Other Names / Subsidiaries
- Abcam plc
- C.B.S. Scientific Company Inc.
- Expedeon Ltd.
- Expedeon AG
- Innova Biosciences Ltd.
- LION Bioscience AG
- SYGNIS AG
- SYGNIS Pharma AG
- TGR Biosciences PTY LTD
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.